IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
$749,955N44FY2016DANIH
Uhv Technologies, Inc., Fort Worth TX
Investigators
Abstract
The purpose of this SBIR Phase II contract is to develop an inexpensive and easy to use instrument that will be capable of measuring low ppm levels (at least <5 ppm) of a range of metals typically used in the pharmaceutical industry. The instrument would be co-located with the reaction and purification equipment where metal removal is performed, and preferably, amenable to continuous monitoring of metal impurities associated with continuous processing operations.
View original record on NIH RePORTER →